Ying RY - Search Results

1

TB-QUICK: CRISPR-Cas12b-assisted rapid and sensitive detection of Mycobacterium tuberculosis.

Sam IK, Chen YY, Ma J, Li SY, Ying RY, Li LX, Ji P, Wang SJ, Xu J, Bao YJ, Zhao GP, Zheng HJ, Wang J, Sha W, Wang Y. Sam IK, et al. Among authors: ying ry. J Infect. 2021 Jul;83(1):54-60. doi: 10.1016/j.jinf.2021.04.032. Epub 2021 May 2. J Infect. 2021. PMID: 33951419

2

In vitro Synergism of Six Antituberculosis Agents Against Drug-Resistant Mycobacterium tuberculosis Isolated from Retreatment Tuberculosis Patients.

Ying R, Huang X, Gao Y, Wang J, Liu Y, Sha W, Yang H. Ying R, et al. Infect Drug Resist. 2021 Sep 14;14:3729-3736. doi: 10.2147/IDR.S322563. eCollection 2021. Infect Drug Resist. 2021. PMID: 34548797 Free PMC article.

3

Antimicrobial Susceptibility Testing Using the MYCO Test System and MIC Distribution of 8 Drugs against Clinical Isolates of Nontuberculous Mycobacteria from Shanghai.

Ying R, Yang J, Wu X, Yu F, Sha W. Ying R, et al. Microbiol Spectr. 2023 Feb 21;11(2):e0254922. doi: 10.1128/spectrum.02549-22. Online ahead of print. Microbiol Spectr. 2023. PMID: 36802218 Free PMC article.

4

Efficacy and safety of an innovative short-course regimen containing clofazimine for treatment of drug-susceptible tuberculosis: a clinical trial.

Zheng X, Gui X, Yao L, Ma J, He Y, Lou H, Gu J, Ying R, Chen L, Sun Q, Liu Y, Ho CM, Lee BY, Clemens DL, Horwitz MA, Ding X, Hao X, Yang H, Sha W. Zheng X, et al. Emerg Microbes Infect. 2023 Dec;12(1):2187247. doi: 10.1080/22221751.2023.2187247. Emerg Microbes Infect. 2023. PMID: 36872899 Free PMC article. Clinical Trial.

5

Metabolic Profiles of Clinical Isolates of Drug-Susceptible and Multidrug-Resistant Mycobacterium tuberculosis: A Metabolomics-Based Study.

Wang L, Ying R, Liu Y, Sun Q, Sha W. Wang L, et al. Infect Drug Resist. 2023 May 3;16:2667-2680. doi: 10.2147/IDR.S405987. eCollection 2023. Infect Drug Resist. 2023. PMID: 37163145 Free PMC article.

6

Correlation between Water Environment and Prevalence of Nontuberculous Mycobacteria Pulmonary Disease: A Case-Control Study.

Shi X, Ying R, Sha W. Shi X, et al. Altern Ther Health Med. 2023 Dec 8:AT9829. Online ahead of print. Altern Ther Health Med. 2023. PMID: 38064622 Free article.

7

Mycobacterium tuberculosis inhibits METTL14-mediated m⁶A methylation of Nox2 mRNA and suppresses anti-TB immunity.

Ma M, Duan Y, Peng C, Wu Y, Zhang X, Chang B, Wang F, Yang H, Zheng R, Cheng H, Cheng Y, He Y, Huang J, Lei J, Ma H, Li L, Wang J, Huang X, Tang F, Liu J, Li J, Ying R, Wang P, Sha W, Gao Y, Wang L, Ge B. Ma M, et al. Cell Discov. 2024 Mar 29;10(1):36. doi: 10.1038/s41421-024-00653-4. Cell Discov. 2024. PMID: 38548762 Free PMC article.

8

Integrating high-throughput phenotypic profiling and transcriptomic analyses to predict the hepatosteatosis effects induced by per- and polyfluoroalkyl substances.

Luo YS, Ying RY, Chen XT, Yeh YJ, Wei CC, Chan CC. Luo YS, et al. Among authors: ying ry. J Hazard Mater. 2024 May 5;469:133891. doi: 10.1016/j.jhazmat.2024.133891. Epub 2024 Feb 27. J Hazard Mater. 2024. PMID: 38457971

9

Analysis of clinical features of COVID-19 in cancer patients.

Cheng WT, Ke YH, Yang GY, Sun H, Chen Y, Ying RY, Zeng XH, Shen D, Tang KJ, Xu K, Yu F. Cheng WT, et al. Among authors: ying ry. Acta Oncol. 2020 Nov;59(11):1393-1396. doi: 10.1080/0284186X.2020.1810313. Epub 2020 Aug 28. Acta Oncol. 2020. PMID: 32857662 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

9 results

Search Page